Effects of subcutaneous interleukin-2 therapy on CD4 subsets and in vitro cytokine production in HIV+ subjects
about
An old enzyme for current needs: adenosine deaminase and a dendritic cell vaccine for HIV.Laureate ESCI award for excellence in clinical science 1999. Cytokines and the human immunodeficiency virus: from bench to bedside. European Society for Clinical Investigation.Immune reconstitution in HIV-1 infected subjects treated with potent antiretroviral therapy.Viral load of human herpesvirus 8 in peripheral blood of human immunodeficiency virus-infected patients with Kaposi's sarcoma.Type 1/Type 2 immunity in infectious diseases.IL-2 immunotherapy to recently HIV-1 infected adults maintains the numbers of IL-17 expressing CD4+ T (T(H)17) cells in the periphery.Use of cytokines in human immunodeficiency virus-infected patients: colony-stimulating factors, erythropoietin, and interleukin-2.Immunological effects of interleukin-2 therapy in human immunodeficiency virus-positive subjectsProspects for IL-16 in the treatment of AIDS.Partial immune reconstitution following highly active antiretroviral therapy: can adjuvant interleukin-2 fill the gap?Natural killer cells from human immunodeficiency virus (HIV)-infected individuals are an important source of CC-chemokines and suppress HIV-1 entry and replication in vitro.Exogenous interleukin-2 administration corrects the cell cycle perturbation of lymphocytes from human immunodeficiency virus-infected individualsAdenosine deaminase potentiates the generation of effector, memory, and regulatory CD4+ T cells.Different rates of CD4+ and CD8+ T-cell proliferation in interleukin-2-treated human immunodeficiency virus-positive subjects.The effects of CD40 ligation on peripheral blood mononuclear cell interleukin-12 and interleukin-15 production and on monocyte CD14 surface antigen expression in human immunodeficiency virus-positive patients.Effects of IL-2 therapy in asymptomatic HIV-infected individuals on proliferative responses to mitogens, recall antigens and HIV-related antigens.Induction of HIV-1-specific T cell responses by administration of cytokines in late-stage patients receiving highly active anti-retroviral therapy
P2860
Q30407263-7807D9D6-3F9C-4B44-AFCE-11846A79B6CBQ33717470-5A203096-6F72-44B1-8C70-1B36B4CA2B49Q33806165-F7BBD410-5C73-4CB4-A7E4-698129113FEAQ33974199-9C4EAAED-5CD4-4150-B87D-F9246A2DC0F2Q34105379-186DA430-049F-4966-898E-8E5F789AC8EFQ34112781-B0B43DE4-D22B-4848-B3DB-8575730E47D5Q34169269-A62CE12D-20D4-45FB-B9BC-5AC9850588C5Q34293966-89282758-6C00-4102-A318-7EE8FD9B6F44Q34451973-8FEB3B31-39E6-4AE6-BF1C-E6E186C92647Q36054268-E8C0FDD5-DF6A-42EE-9C58-EE14726DECB9Q37387255-B7F011DC-531B-4595-98C2-87E5DF08DD95Q39605011-170BFA3D-320D-4E65-8DF3-410C1546067EQ43840575-8B01C5D6-A299-425C-80C9-427DC8E6F407Q45735994-927DF0CA-767C-450B-828D-65F3D40C4D47Q45750402-605BE891-C316-4B38-B7C4-BE962E91C522Q47712334-47C0DFC8-9ABB-459E-AE56-181D82583912Q57384728-6BC9FA34-8C58-4D2F-A226-AD0D766BC649
P2860
Effects of subcutaneous interleukin-2 therapy on CD4 subsets and in vitro cytokine production in HIV+ subjects
description
1997 nî lūn-bûn
@nan
1997年の論文
@ja
1997年論文
@yue
1997年論文
@zh-hant
1997年論文
@zh-hk
1997年論文
@zh-mo
1997年論文
@zh-tw
1997年论文
@wuu
1997年论文
@zh
1997年论文
@zh-cn
name
Effects of subcutaneous interl ...... ne production in HIV+ subjects
@en
Effects of subcutaneous interl ...... e production in HIV+ subjects.
@nl
type
label
Effects of subcutaneous interl ...... ne production in HIV+ subjects
@en
Effects of subcutaneous interl ...... e production in HIV+ subjects.
@nl
prefLabel
Effects of subcutaneous interl ...... ne production in HIV+ subjects
@en
Effects of subcutaneous interl ...... e production in HIV+ subjects.
@nl
P2093
P2860
P356
P1476
Effects of subcutaneous interl ...... ne production in HIV+ subjects
@en
P2093
Bortolin MT
Crepaldi C
D'Andrea M
De Paoli P
Simonelli C
Talamini R
P2860
P304
P356
10.1172/JCI119819
P407
P577
1997-12-01T00:00:00Z